Travere Therapeutics, Inc.
Industry: Life Sciences ・ $TVTX on Nasdaq
Insider Sale
+$25,240
-1.99%
Shares
Shares Volume: 2,191 Shares
Average Share Price: $11.52
INSIDER
Heerma Peter
CHIEF COMMERCIAL OFFICER (Officer)
reported on Sep 9 2024
traded on Sep 5 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 107,958 |
| PURCHASES/SALES 1Y | 0 / 3 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $25,054.6 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 0 / 18 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $32,243.86 |
| COMPANY PREVIOUS TRADES |